End Cash: The amount of cash held by the company for the given period.
AC Immune (ACIU) had End Cash of $35.12M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$118.18M |
|
$2.43M |
|
$72.12M |
|
$190.30M |
|
$126.83M |
|
-- |
|
$18.97M |
|
$145.80M |
|
$44.49M |
|
$-19.29M |
|
$44.50M |
|
-- |
|
| Cash Flow Statement Financials | |
$-19.80M |
|
$20.99M |
|
$0.18M |
|
$33.90M |
|
|
End Cash |
$35.12M |
$1.22M |
|
$3.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|